Abstract
Ryan C. Maloney
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
10.1172/jci33656
10.1172/jci33656
Regulation of RAF protein kinases in ERK signalling
10.1038/nrm3979 · 2015
10.1016/j.sbi.2018.07.007
10.1016/j.sbi.2018.07.007
10.1073/pnas.0607656103
10.1073/pnas.0607656103
Germline gain-of-function mutations in RAF1 cause
2007
10.1038/nature00766
10.1038/nature00766
10.1074/jbc.m501185200
10.1074/jbc.m501185200
10.1128/mcb.00057-14
10.1128/mcb.00057-14
10.1098/rstb.2012.0054
10.1098/rstb.2012.0054
Emerging BRAF mutations in cancer progression and their possible effects on transcriptional networks
10.3390/genes11111342 · 2020
10.1038/emboj.2012.100
10.1038/emboj.2012.100
10.1038/nature23291
10.1038/nature23291
The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
10.1186/s12967-019-2036-7 · 2019
10.1038/nrc3760
10.1038/nrc3760
Unresolved referenced work
2018
Autoregulation of the Raf-1 serine/threonine kinase
10.1073/pnas.95.16.9214 · 1998
The amino-terminal B-Raf-specific region mediates calcium-dependent homo- and hetero-dimerization of Raf
10.1038/sj.emboj.7601241 · 2006
10.1016/j.ccr.2014.07.007
10.1016/j.ccr.2014.07.007
10.1126/science.8085158
10.1126/science.8085158
10.1073/pnas.1318188110
10.1073/pnas.1318188110
10.1039/c5cs00911a
10.1039/c5cs00911a
Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain
10.1038/s41598-018-26832-4 · 2018
10.3389/fonc.2019.01231
10.3389/fonc.2019.01231
Unresolved referenced work
1999
10.1016/j.str.2018.01.011
10.1016/j.str.2018.01.011
Ras assemblies and signaling at the membrane
10.1016/j.sbi.2020.01.009 · 2020
Unresolved referenced work
Kept as external metadata until matched
10.1016/j.cell.2013.07.046
10.1016/j.cell.2013.07.046
10.1016/j.csbj.2019.12.004
10.1016/j.csbj.2019.12.004
10.1016/s0021-9258(19)85336-x
10.1016/s0021-9258(19)85336-x
10.1042/bj3510289
10.1042/bj3510289
10.1073/pnas.94.24.12792
10.1073/pnas.94.24.12792
10.1038/nature08314
10.1038/nature08314
V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors
10.1073/pnas.0609973103 · 2006
10.1038/sj.onc.1207185
10.1038/sj.onc.1207185
10.1016/j.molcel.2004.11.055
10.1016/j.molcel.2004.11.055
10.1042/bj20120938
10.1042/bj20120938
10.1038/nature14982
10.1038/nature14982
Unresolved referenced work
2015
10.1158/1535-7163.mct-15-0617
10.1158/1535-7163.mct-15-0617
10.1158/0008-5472.can-20-0911
10.1158/0008-5472.can-20-0911 · doi-reference
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma
10.1016/j.cub.2005.01.031 · doi-reference
Classifying kinase conformations using a machine learning approach
10.1186/s12859-017-1506-2 · doi-reference
10.1073/pnas.1814279116
10.1073/pnas.1814279116 · doi-reference
10.1126/sciadv.1600663
10.1126/sciadv.1600663 · doi-reference
Biochemical Characterization of Full-Length Oncogenic BRAF(V600E) together with molecular dynamics simulations provide insight into the activation and inhibition mechanisms of RAF Kinases
10.1002/cbic.201900266 · doi-reference
Identification and Characterization of a B-Raf Kinase α-Helix Critical for the Activity of MEK Kinase in MAPK Signaling
10.1021/acs.biochem.0c00598 · doi-reference
10.1021/acs.jpcb.8b05982
10.1021/acs.jpcb.8b05982 · doi-reference
10.1021/acs.biochem.9b00854
10.1021/acs.biochem.9b00854 · doi-reference
10.1039/c9cp00101h
10.1039/c9cp00101h · doi-reference
10.1039/c8sc04498h
10.1039/c8sc04498h · doi-reference
10.1016/j.bpj.2017.09.008
10.1016/j.bpj.2017.09.008 · doi-reference
10.1021/acs.jpcb.8b04347
10.1021/acs.jpcb.8b04347 · doi-reference
10.1074/jbc.ra117.001596
10.1074/jbc.ra117.001596 · doi-reference
10.1021/acs.jpcb.7b03035
10.1021/acs.jpcb.7b03035 · doi-reference
The dynamic mechanism of RASSF5 and MST kinase activation by Ras
10.1039/c6cp08596b · doi-reference
SOS1 interacts with Grb2 through regions that induce closed nSH3 conformations
10.1063/5.0013926 · doi-reference
10.1016/j.bpj.2018.07.016
10.1016/j.bpj.2018.07.016 · doi-reference
10.1016/j.str.2019.08.009
10.1016/j.str.2019.08.009 · doi-reference
10.1074/jbc.m117.785063
10.1074/jbc.m117.785063 · doi-reference
Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region
10.1074/jbc.m114.620724 · doi-reference
10.1016/j.bpj.2015.09.034
10.1016/j.bpj.2015.09.034 · doi-reference
10.1021/acs.jpcb.5b11110
10.1021/acs.jpcb.5b11110 · doi-reference
10.1038/nmeth.4067
10.1038/nmeth.4067 · doi-reference
10.1021/jp101759q
10.1021/jp101759q · doi-reference
10.1002/jcc.20289
10.1002/jcc.20289 · doi-reference
10.1093/nar/gky427
10.1093/nar/gky427 · doi-reference
10.1002/jcc.21287
10.1002/jcc.21287 · doi-reference
10.3390/cancers11081197
10.3390/cancers11081197 · doi-reference
10.1038/s41467-020-18123-2
10.1038/s41467-020-18123-2 · doi-reference
Design and Synthesis of Type-IV Inhibitors of BRAF kinase that block dimerization and overcome paradoxical MEK/ERK Activation
10.1021/acs.jmedchem.8b01288 · doi-reference
10.1016/j.ccell.2015.08.002
10.1016/j.ccell.2015.08.002 · doi-reference
Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
10.1038/bjc.2014.139 · doi-reference
10.1038/nature08902
10.1038/nature08902 · doi-reference
10.1016/s0140-6736(12)60868-x
10.1016/s0140-6736(12)60868-x · doi-reference
10.1073/pnas.0711741105
10.1073/pnas.0711741105 · doi-reference
10.1200/jco.2009.27.15_suppl.9000
10.1200/jco.2009.27.15_suppl.9000 · doi-reference
10.15252/embj.201694732
10.15252/embj.201694732 · doi-reference
10.1038/s41388-018-0365-2
10.1038/s41388-018-0365-2 · doi-reference
10.1016/j.molcel.2012.12.018
10.1016/j.molcel.2012.12.018 · doi-reference